Loading…

Post-COVID syndrome: Clinical pattern and impact on health related quality of life

Background COVID-19 management has changed from just dealing with a novel respiratory viral illness to unraveling the mystery of a systemic disease. This study aimed to assess clinical pattern for post-COVID survivors and impact on quality of life. Methods 115 Patients suffering from COVID-19 affect...

Full description

Saved in:
Bibliographic Details
Published in:Egyptian Journal of Chest Disease and Tuberculosis 2024-07, Vol.73 (3), p.248-260
Main Authors: Mohamed, Ashraf Zin EL-Abdeen, Shaaban, Lamiaa Hassan, Attia, Mostafa Mahmoud, Khaleel, Waleed Gamal Elddin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c190t-ffbf24cfb66bfe3c2a806736cf46ed23c08164b682ba36cbf526817b12d66b6a3
container_end_page 260
container_issue 3
container_start_page 248
container_title Egyptian Journal of Chest Disease and Tuberculosis
container_volume 73
creator Mohamed, Ashraf Zin EL-Abdeen
Shaaban, Lamiaa Hassan
Attia, Mostafa Mahmoud
Khaleel, Waleed Gamal Elddin
description Background COVID-19 management has changed from just dealing with a novel respiratory viral illness to unraveling the mystery of a systemic disease. This study aimed to assess clinical pattern for post-COVID survivors and impact on quality of life. Methods 115 Patients suffering from COVID-19 affection were recruited in this study. The assessment included clinical history with special attention to symptoms attributable to post-COVID manifestations. Evaluation for presence of insomnia, anxiety and depression were done using insomnia severity index (ISI), Hamilton’s anxiety (HAM-A) and depression rating scales (HAM-D), respectively. Laboratory investigations included complete blood count (CBC), kidney function test, liver function test, C-reactive protein (CRP), and inflammatory markers including ESR, CRP and Ferritin level. EQ-5D-5L and EQ visual analogue scale (EQ-VAS) were used to assess participants’ overall health status and quality of life. Results COVID-19 patients suffered from cough (76%), fever (72.9%), fatigue (72.9%), dyspnea (69.8%) and muscle/joint pain (66.1%) as the most distressing symptoms during period of acute infection. Regarding post-COVID syndrome (PCS); Dyspnea (32.2%), fatigue (26.1%), muscle/joint pain (22.6%), loss of taste (16.5%) and loss of smell (15.7%) were the most prevalent at 3 month evaluation. 46.9% patients developed manifestations attributable to post-COVID syndrome. Fever, cough, loss of smell and taste, fatigue, anxiety and insomnia persisted significantly for longer periods among severe cases (Group 2). EQ-5D-5L domains were significantly impaired among severe COVID patients. Significant positive correlation noticed between age and increased duration of dyspnea, muscle/joint pains and depression. Also, CT chest severity scores showed significant correlation with dyspnea, fatigue, muscle/joint pains (P=0.023, 0.012 and
doi_str_mv 10.4103/ecdt.ecdt_6_24
format article
fullrecord <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_35b71c3882b741e4902844f9c5139536</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_35b71c3882b741e4902844f9c5139536</doaj_id><sourcerecordid>oai_doaj_org_article_35b71c3882b741e4902844f9c5139536</sourcerecordid><originalsourceid>FETCH-LOGICAL-c190t-ffbf24cfb66bfe3c2a806736cf46ed23c08164b682ba36cbf526817b12d66b6a3</originalsourceid><addsrcrecordid>eNo9kM1KAzEYRYMoWGq3rvMCU_M3mcSdjH-FQkXUbUgyiU1JJzUTF317p630W9wPLtyzOADcYjRnGNE7Z7syP4TiirALMCFIokrKGl2CCWKEVA2n4hrMhmGDxhM1lpRNwPtbGkrVrr4Wj3DY911OW3cP2xj6YHWEO12Kyz3UfQfDdqdtgamHa6djWcPsoi6ugz-_Ooayh8nDGLy7AVdex8HN_v8UfD4_fbSv1XL1smgflpXFEpXKe-MJs95wbryjlmiBeEO59Yy7jlCLBObMcEGMHlvja8IFbgwm3bjgmk7B4sTtkt6oXQ5bnfcq6aCORcrfSucSbHSK1qbBloqR1TDsmEREMOalrTGVNeUja35i2ZyGITt_5mGkDoLV0e1ZMP0DlwZvmg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Post-COVID syndrome: Clinical pattern and impact on health related quality of life</title><source>Medknow Open Access Medical Journals</source><creator>Mohamed, Ashraf Zin EL-Abdeen ; Shaaban, Lamiaa Hassan ; Attia, Mostafa Mahmoud ; Khaleel, Waleed Gamal Elddin</creator><creatorcontrib>Mohamed, Ashraf Zin EL-Abdeen ; Shaaban, Lamiaa Hassan ; Attia, Mostafa Mahmoud ; Khaleel, Waleed Gamal Elddin</creatorcontrib><description>Background COVID-19 management has changed from just dealing with a novel respiratory viral illness to unraveling the mystery of a systemic disease. This study aimed to assess clinical pattern for post-COVID survivors and impact on quality of life. Methods 115 Patients suffering from COVID-19 affection were recruited in this study. The assessment included clinical history with special attention to symptoms attributable to post-COVID manifestations. Evaluation for presence of insomnia, anxiety and depression were done using insomnia severity index (ISI), Hamilton’s anxiety (HAM-A) and depression rating scales (HAM-D), respectively. Laboratory investigations included complete blood count (CBC), kidney function test, liver function test, C-reactive protein (CRP), and inflammatory markers including ESR, CRP and Ferritin level. EQ-5D-5L and EQ visual analogue scale (EQ-VAS) were used to assess participants’ overall health status and quality of life. Results COVID-19 patients suffered from cough (76%), fever (72.9%), fatigue (72.9%), dyspnea (69.8%) and muscle/joint pain (66.1%) as the most distressing symptoms during period of acute infection. Regarding post-COVID syndrome (PCS); Dyspnea (32.2%), fatigue (26.1%), muscle/joint pain (22.6%), loss of taste (16.5%) and loss of smell (15.7%) were the most prevalent at 3 month evaluation. 46.9% patients developed manifestations attributable to post-COVID syndrome. Fever, cough, loss of smell and taste, fatigue, anxiety and insomnia persisted significantly for longer periods among severe cases (Group 2). EQ-5D-5L domains were significantly impaired among severe COVID patients. Significant positive correlation noticed between age and increased duration of dyspnea, muscle/joint pains and depression. Also, CT chest severity scores showed significant correlation with dyspnea, fatigue, muscle/joint pains (P=0.023, 0.012 and &lt;0.001; respectively). Conclusion High prevalence of Post-COVID syndrome is a challenge to health care resources. PCS directly impacts mobility, self-care, usual activities, pain perception and anxiety and therefore is associated with lower quality of life among post-COVID patients.</description><identifier>ISSN: 0422-7638</identifier><identifier>EISSN: 2090-9950</identifier><identifier>DOI: 10.4103/ecdt.ecdt_6_24</identifier><language>eng</language><publisher>Wolters Kluwer Medknow Publications</publisher><subject>anxiety; eq-5d-5l; long covid; post-covid syndrome; quality of life</subject><ispartof>Egyptian Journal of Chest Disease and Tuberculosis, 2024-07, Vol.73 (3), p.248-260</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c190t-ffbf24cfb66bfe3c2a806736cf46ed23c08164b682ba36cbf526817b12d66b6a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Mohamed, Ashraf Zin EL-Abdeen</creatorcontrib><creatorcontrib>Shaaban, Lamiaa Hassan</creatorcontrib><creatorcontrib>Attia, Mostafa Mahmoud</creatorcontrib><creatorcontrib>Khaleel, Waleed Gamal Elddin</creatorcontrib><title>Post-COVID syndrome: Clinical pattern and impact on health related quality of life</title><title>Egyptian Journal of Chest Disease and Tuberculosis</title><description>Background COVID-19 management has changed from just dealing with a novel respiratory viral illness to unraveling the mystery of a systemic disease. This study aimed to assess clinical pattern for post-COVID survivors and impact on quality of life. Methods 115 Patients suffering from COVID-19 affection were recruited in this study. The assessment included clinical history with special attention to symptoms attributable to post-COVID manifestations. Evaluation for presence of insomnia, anxiety and depression were done using insomnia severity index (ISI), Hamilton’s anxiety (HAM-A) and depression rating scales (HAM-D), respectively. Laboratory investigations included complete blood count (CBC), kidney function test, liver function test, C-reactive protein (CRP), and inflammatory markers including ESR, CRP and Ferritin level. EQ-5D-5L and EQ visual analogue scale (EQ-VAS) were used to assess participants’ overall health status and quality of life. Results COVID-19 patients suffered from cough (76%), fever (72.9%), fatigue (72.9%), dyspnea (69.8%) and muscle/joint pain (66.1%) as the most distressing symptoms during period of acute infection. Regarding post-COVID syndrome (PCS); Dyspnea (32.2%), fatigue (26.1%), muscle/joint pain (22.6%), loss of taste (16.5%) and loss of smell (15.7%) were the most prevalent at 3 month evaluation. 46.9% patients developed manifestations attributable to post-COVID syndrome. Fever, cough, loss of smell and taste, fatigue, anxiety and insomnia persisted significantly for longer periods among severe cases (Group 2). EQ-5D-5L domains were significantly impaired among severe COVID patients. Significant positive correlation noticed between age and increased duration of dyspnea, muscle/joint pains and depression. Also, CT chest severity scores showed significant correlation with dyspnea, fatigue, muscle/joint pains (P=0.023, 0.012 and &lt;0.001; respectively). Conclusion High prevalence of Post-COVID syndrome is a challenge to health care resources. PCS directly impacts mobility, self-care, usual activities, pain perception and anxiety and therefore is associated with lower quality of life among post-COVID patients.</description><subject>anxiety; eq-5d-5l; long covid; post-covid syndrome; quality of life</subject><issn>0422-7638</issn><issn>2090-9950</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9kM1KAzEYRYMoWGq3rvMCU_M3mcSdjH-FQkXUbUgyiU1JJzUTF317p630W9wPLtyzOADcYjRnGNE7Z7syP4TiirALMCFIokrKGl2CCWKEVA2n4hrMhmGDxhM1lpRNwPtbGkrVrr4Wj3DY911OW3cP2xj6YHWEO12Kyz3UfQfDdqdtgamHa6djWcPsoi6ugz-_Ooayh8nDGLy7AVdex8HN_v8UfD4_fbSv1XL1smgflpXFEpXKe-MJs95wbryjlmiBeEO59Yy7jlCLBObMcEGMHlvja8IFbgwm3bjgmk7B4sTtkt6oXQ5bnfcq6aCORcrfSucSbHSK1qbBloqR1TDsmEREMOalrTGVNeUja35i2ZyGITt_5mGkDoLV0e1ZMP0DlwZvmg</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Mohamed, Ashraf Zin EL-Abdeen</creator><creator>Shaaban, Lamiaa Hassan</creator><creator>Attia, Mostafa Mahmoud</creator><creator>Khaleel, Waleed Gamal Elddin</creator><general>Wolters Kluwer Medknow Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>202407</creationdate><title>Post-COVID syndrome: Clinical pattern and impact on health related quality of life</title><author>Mohamed, Ashraf Zin EL-Abdeen ; Shaaban, Lamiaa Hassan ; Attia, Mostafa Mahmoud ; Khaleel, Waleed Gamal Elddin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c190t-ffbf24cfb66bfe3c2a806736cf46ed23c08164b682ba36cbf526817b12d66b6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>anxiety; eq-5d-5l; long covid; post-covid syndrome; quality of life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohamed, Ashraf Zin EL-Abdeen</creatorcontrib><creatorcontrib>Shaaban, Lamiaa Hassan</creatorcontrib><creatorcontrib>Attia, Mostafa Mahmoud</creatorcontrib><creatorcontrib>Khaleel, Waleed Gamal Elddin</creatorcontrib><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Egyptian Journal of Chest Disease and Tuberculosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohamed, Ashraf Zin EL-Abdeen</au><au>Shaaban, Lamiaa Hassan</au><au>Attia, Mostafa Mahmoud</au><au>Khaleel, Waleed Gamal Elddin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Post-COVID syndrome: Clinical pattern and impact on health related quality of life</atitle><jtitle>Egyptian Journal of Chest Disease and Tuberculosis</jtitle><date>2024-07</date><risdate>2024</risdate><volume>73</volume><issue>3</issue><spage>248</spage><epage>260</epage><pages>248-260</pages><issn>0422-7638</issn><eissn>2090-9950</eissn><abstract>Background COVID-19 management has changed from just dealing with a novel respiratory viral illness to unraveling the mystery of a systemic disease. This study aimed to assess clinical pattern for post-COVID survivors and impact on quality of life. Methods 115 Patients suffering from COVID-19 affection were recruited in this study. The assessment included clinical history with special attention to symptoms attributable to post-COVID manifestations. Evaluation for presence of insomnia, anxiety and depression were done using insomnia severity index (ISI), Hamilton’s anxiety (HAM-A) and depression rating scales (HAM-D), respectively. Laboratory investigations included complete blood count (CBC), kidney function test, liver function test, C-reactive protein (CRP), and inflammatory markers including ESR, CRP and Ferritin level. EQ-5D-5L and EQ visual analogue scale (EQ-VAS) were used to assess participants’ overall health status and quality of life. Results COVID-19 patients suffered from cough (76%), fever (72.9%), fatigue (72.9%), dyspnea (69.8%) and muscle/joint pain (66.1%) as the most distressing symptoms during period of acute infection. Regarding post-COVID syndrome (PCS); Dyspnea (32.2%), fatigue (26.1%), muscle/joint pain (22.6%), loss of taste (16.5%) and loss of smell (15.7%) were the most prevalent at 3 month evaluation. 46.9% patients developed manifestations attributable to post-COVID syndrome. Fever, cough, loss of smell and taste, fatigue, anxiety and insomnia persisted significantly for longer periods among severe cases (Group 2). EQ-5D-5L domains were significantly impaired among severe COVID patients. Significant positive correlation noticed between age and increased duration of dyspnea, muscle/joint pains and depression. Also, CT chest severity scores showed significant correlation with dyspnea, fatigue, muscle/joint pains (P=0.023, 0.012 and &lt;0.001; respectively). Conclusion High prevalence of Post-COVID syndrome is a challenge to health care resources. PCS directly impacts mobility, self-care, usual activities, pain perception and anxiety and therefore is associated with lower quality of life among post-COVID patients.</abstract><pub>Wolters Kluwer Medknow Publications</pub><doi>10.4103/ecdt.ecdt_6_24</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0422-7638
ispartof Egyptian Journal of Chest Disease and Tuberculosis, 2024-07, Vol.73 (3), p.248-260
issn 0422-7638
2090-9950
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_35b71c3882b741e4902844f9c5139536
source Medknow Open Access Medical Journals
subjects anxiety
eq-5d-5l
long covid
post-covid syndrome
quality of life
title Post-COVID syndrome: Clinical pattern and impact on health related quality of life
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A53%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Post-COVID%20syndrome:%20Clinical%20pattern%20and%20impact%20on%20health%20related%20quality%20of%20life&rft.jtitle=Egyptian%20Journal%20of%20Chest%20Disease%20and%20Tuberculosis&rft.au=Mohamed,%20Ashraf%20Zin%20EL-Abdeen&rft.date=2024-07&rft.volume=73&rft.issue=3&rft.spage=248&rft.epage=260&rft.pages=248-260&rft.issn=0422-7638&rft.eissn=2090-9950&rft_id=info:doi/10.4103/ecdt.ecdt_6_24&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_35b71c3882b741e4902844f9c5139536%3C/doaj_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c190t-ffbf24cfb66bfe3c2a806736cf46ed23c08164b682ba36cbf526817b12d66b6a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true